NEUROCRINE BIOSCIENCES, INC. (NBIX) Free cash flow 2016–2025
NEUROCRINE BIOSCIENCES, INC. (NBIX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$748.7MFY2025 · since FY2016: -$110.3M → $748.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $748.7M | +34.4% |
| FY2024 | $557.2M | +54.1% |
| FY2023 | $361.6M | +12.0% |
| FY2022 | $322.9M | +38.5% |
| FY2021 | $233.1M | +7.1% |
| FY2020 | $217.6M | +64.5% |
| FY2019 | $132.3M | +72.7% |
| FY2018 | $76.6M | +175.6% |
| FY2017 | -$101.3M | +8.2% |
| FY2016 | -$110.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice